Cureline, Inc.
Since 2003, Cureline, Inc. has been dedicated to innovation in human tissue research. Using scientific and clinical expertise, Cureline has developed multi-site international collaborations and implemented protocols for obtaining, handling and processing of human specimens worldwide. Since the beginning, the primary focus of Cureline has been oncology, including solid tumors and hematologic malignancies. Every year their procurement network expands to new therapeutic areas and new countries and are now conducting projects in neurology, inflammation and metabolic and cardiovascular diseases.
For more information, visit www.cureline.com..
